Skip to content

Clinical Parameters and Biological Markers associated with Acute Severe Ocular Complications in Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis in Thailand

Clinical Parameters and Biological Markers associated with Acute Severe Ocular Complications in Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis in Thailand

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
TCTR
Registry ID
TCTR20210729002
Enrollment
50
Registered
2021-07-29
Start date
2020-08-01
Completion date
Unknown
Last updated
2026-08-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Acute Ocular Complications in Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis in Thailand Stevens-Johnson Syndrome Toxic Epidermal Necrolysis Severe cutaneous adverse reaction SCAR Type IV hypersensitivity reaction Delayed T-cell-mediated type hypersensitivity reaction Drug-induced SJS and TEN Drug reaction Culprit drugs Ocular complication Severe ocular complications Ocular involvement Biomarkers Asian Southeast Asian

Interventions

ocular severity score grade 0 - 2 ,ocular severity score grade 3
Screening,Screening
Severe ocular complications,Severe ocular complications

Sponsors

Ratchadapisek Sompoch Endowment Fund
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 90 Years

Inclusion criteria

Inclusion criteria: 1. Patients in Thai SCARs database (dermatological diagnosis of SJS or TEN or SJS-TEN overlap) with ocular involvement 2. The patients had medical records of the acute phase, which were fully accessible to evaluate prognostic factors 3. The patients did not have a history of other ocular surface disorder or ocular surgery

Exclusion criteria

Exclusion criteria: 1. Clinical information was insufficient to calculate the SCORTEN 2. Sepsis (in serum analysis) 3. Positive blood culture (in serum analysis)

Design outcomes

Primary

MeasureTime frame
Clinical factors of acute severe ocular complications in SJS/TEN patients Acute phase of SJS/TEN (with in 2 weeks after onset of SJS/TEN) Severity scores for TEN (SCORTEN), Grading score for acute ocular severity of SJS/TEN

Secondary

MeasureTime frame
Biological markers for acute severe ocular complications in SJS/TEN patients Serum from acute phase of SJS/TEN (with in 2 weeks after onset of SJS/TEN) samples were analyzed using a bead-based multiplex immunoassay

Countries

Thailand

Contacts

Public ContactRawiphan Panpruk

Chulalongkorn University

prmdcu@gmail.com6622564144

Outcome results

None listed

Source: TCTR (via WHO ICTRP) · Data processed: Aug 9, 2026